SCHEMBL2495320

SCHEMBL2495320

COc1ccccc1C1(NC(C)(C)C(=O)N(C)C)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.42
▸ CBX7 O95931 1/20 0.40
▸ CDYL Q9Y232 1/20 0.40
▸ KCNMA1 Q12791 2/20 0.39
▸ KCNQ3 O43525 1/20 0.39
▸ KCNQ2 O43526 1/20 0.39
▸ KCNQ4 P56696 1/20 0.39
▸ KCNQ5 Q9NR82 1/20 0.39
▸ IDO1 P14902 2/20 0.38
▸ ADAMTS5 Q9UNA0 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ ACHE P22303 4/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ ADCY8 P40145 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ AVPR2 P30518 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2495994 0.82 KMT2A (0.44) KMT2ACBX7CDYLKCNMA1KCNQ3
SCHEMBL2497477 0.80 KMT2A (0.42) KMT2ACBX7CDYLKCNMA1KCNQ3
SCHEMBL2492996 0.80 KMT2A (0.42) KMT2ACBX7CDYLKCNMA1KCNQ3
SCHEMBL2496302 0.78 KMT2A (0.41) KMT2ACBX7CDYLKCNMA1KCNQ3
SCHEMBL2496818 0.78 KMT2A (0.42) KMT2ACBX7CDYLKCNMA1KCNQ3
SCHEMBL2496408 0.78 CBX7 (0.40) KMT2ACBX7CDYLKCNMA1KCNQ3
SCHEMBL2492829 0.78 KMT2A (0.40) KMT2ACBX7CDYLKCNMA1KCNQ3
SCHEMBL2493282 0.78 KMT2A (0.40) KMT2ACBX7CDYLKCNMA1KCNQ3
SCHEMBL2500207 0.78 KMT2A (0.40) KMT2ACBX7CDYLKCNMA1KCNQ3
SCHEMBL5675323 0.77 CBX7 (0.47) KMT2ACBX7CDYLKCNMA1KCNQ3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 — — US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 KMT2A 1662/4885CBX7 4226/4885CDYL 3793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback